Latest Uk Market Entry News

Premier Investments reported a 31.1% rise in net profit after tax for FY25, driven by strong growth in its continuing operations after divesting its Apparel Brands to Myer. The company is now concentrating on expanding its high-margin Peter Alexander and Smiggle brands.

Premier Investments reported a 31% jump in net profit to $338.2 million for FY25, driven by the sale of Just Group and a $1.03 billion fully franked In-Specie Distribution to shareholders. Continuing operations showed a profit decline amid strategic brand investments.

Halo Technologies Holdings Ltd has announced a renounceable pro rata rights issue aiming to raise up to $11 million at $0.024 per share, partially underwritten by Lodge Corporate Pty Ltd. The capital raise will support the company’s UK market entry, local growth, and ongoing software development.

PEXA Group Ltd reported a robust FY25 with 16% revenue growth and a 21% rise in EBITDA, driven by national expansion and operational efficiencies. The company is advancing its UK platform launch backed by NatWest, while FY26 guidance signals continued growth and strategic focus on AI and resilience.

HITIQ Limited is set to debut its PROTEQT concussion management system in the UK on August 4, 2025, uniquely integrating with NHS 111 telehealth services to offer free medical guidance. This launch marks HITIQ’s first international consumer market entry and a strategic step in its global expansion.

HALO Technologies reports a robust 45.5% increase in operating revenue for 2024, driven by surging Funds Under Management and brokerage income, while advancing its UK market entry alongside a $6.75 million capital raise.

Wellnex Life Limited reported a 36% rise in Q2 FY25 cash receipts and record monthly sales, while advancing its dual listing on the London Stock Exchange and expanding into the UK market.

Microba Life Sciences reports a remarkable 102% revenue increase in Q2 FY25, driven by strong sales of its MetaXplore test in Australia and promising early traction in the UK. The company also advances its therapeutic pipeline with key clinical milestones.

Love Group Global Ltd posts a 4% rise in quarterly customer cash receipts, driven by strong growth in Singapore, while preparing to expand matchmaking services into the UK.